In the present study, using immunohistochemistry, immunoblotting, quantitative real-time PCR (qRT-PCR) and proteomics profiling by mass spectroscopy, we demonstrate that tumor reprograming is dependent on the duration that the tumor was depleted of VDAC1. The gene discussed is VDAC1; the disease is neoplasm.